Differentially expressed genes in this pathway are shown in Fig. 4C. Through analysis and research, the CYP1A1 protein was found to be highly expressed in various breast cancer and gynecological tumors, and these differential genes may be involved in the NF-κB signaling pathway and the regulation of tumor immunity. The gene discussed is CYP1A1; the disease is breast carcinoma.